Drugs / Anti-BCMA CAR-NK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06242249 | Apr 2024 → Apr 2026 | plasma cell myeloma | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-BCMA CAR-NK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06242249 ↗ |
| Modality | Cell therapy | “CAR-NK cell therapy” NCT06242249 ↗ |